Over at Genetic Future, Daniel MacArthur is wondering what everyone wants to know: why buy Navigenics' Annual Insight service for $500 when you can have 23andMe's full genome scan for $100 cheaper? Navigenics recently announced an alternative to its $2,500 genetic testing service, the Annual Insight service, which costs $499 and analyzes genetic predisposition for ten common health conditions, including breast cancer, prostate cancer, colon cancer, and heart disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.